ZFYVE20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.205040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.839600E-01
Normal-vs-Stage2
1.282370E-01
Normal-vs-Stage3
3.453900E-02
Normal-vs-Stage4
6.100600E-01
Stage1-vs-Stage2
6.295800E-01
Stage1-vs-Stage3
1.105040E-01
Stage1-vs-Stage4
6.102000E-01
Stage2-vs-Stage3
8.617600E-02
Stage2-vs-Stage4
2.938800E-01
Stage3-vs-Stage4
2.887700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.193440E-01
Normal-vs-AfricanAmerican
3.321000E-01
Normal-vs-Asian
1.267210E-01
Caucasian-vs-AfricanAmerican
9.341800E-01
Caucasian-vs-Asian
5.678000E-01
AfricanAmerican-vs-Asian
7.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.062020E-01
Normal-vs-Female
1.580430E-01
Male-vs-Female
3.570800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.780600E-01
Normal-vs-Age(41-60Yrs)
2.493600E-01
Normal-vs-Age(61-80Yrs)
9.086100E-02
Normal-vs-Age(81-100Yrs)
6.066100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.293600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.733990E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.204300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.819880E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.425500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.337400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.784000E-02
Normal-vs-Daily Drinker
4.077700E-02
Normal-vs-Weekly Drinker
2.691400E-01
Normal-vs-Occasional Drinker
9.176100E-02
Normal-vs-Social Drinker
5.455600E-01
Non Drinker-vs-Daily Drinker
9.250600E-01
Non Drinker-vs-Weekly Drinker
1.328380E-01
Non Drinker-vs-Occasional Drinker
2.779200E-01
Non Drinker-vs-Social Drinker
4.443600E-02
Daily Drinker-vs-Weekly Drinker
1.532210E-01
Daily Drinker-vs-Occasional Drinker
3.138000E-01
Daily Drinker-vs-Social Drinker
6.068500E-02
Weekly Drinker-vs-Occasional Drinker
5.589600E-01
Weekly Drinker-vs-Social Drinker
5.973200E-01
Occasional Drinker-vs-Social Drinker
2.658600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.671000E-01
Normal-vs-Grade 2
6.286200E-01
Normal-vs-Grade 3
6.474800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.651500E-02
Grade 1-vs-Grade 3
2.040600E-01
Grade 1-vs-Grade 4
4.671000E-01
Grade 2-vs-Grade 3
6.851000E-01
Grade 2-vs-Grade 4
6.286200E-01
Grade 3-vs-Grade 4
6.474800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.627160E-01
Normal-vs-NonDiabetic
7.447800E-02
Diabetic-vs-NonDiabetic
8.569800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.605400E-01
Normal-vs-NoPancreatitis
8.307500E-02
Pancreatitis-vs-NoPancreatitis
3.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.082640E-01
Normal-vs-N1
1.261850E-01
N0-vs-N1
7.372600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.303420E-01
Normal-vs-TP53-NonMutant
3.882800E-01
TP53-Mutant-vs-TP53-NonMutant
2.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
